With A Novel Pipeline, Pfizer Tries A New Oncology Business Unit Too

With a lot of determination and a lot of licensing, Pfizer has managed to pack its oncology pipeline with novel mechanisms. Now the company is trying to innovate its business organization to make the most of what it has